Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Minisini

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 6, 2024
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoidsTeresa Gagliano, Emanuela Kerschbamer, Umberto Baccarani, et al.
Cell Death Discovery|November 10, 2025
Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cellsEleonora Malavasi, Raffaella Picco, Showmeya Mallavarapu, et al.
Molecular Cancer Therapeutics|March 31, 2021
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>Luca Iuliano, Sara Drioli, Ymera Pignochino, et al.
Nucleic Acids Research|February 12, 2022
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcriptionMartina Minisini, Eros Di Giorgio, Emanuela Kerschbamer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 6, 2024
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoidsTeresa Gagliano, Emanuela Kerschbamer, Umberto Baccarani, et al.
Cell Death Discovery|November 10, 2025
Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cellsEleonora Malavasi, Raffaella Picco, Showmeya Mallavarapu, et al.
Molecular Cancer Therapeutics|March 31, 2021
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>Luca Iuliano, Sara Drioli, Ymera Pignochino, et al.
Nucleic Acids Research|February 12, 2022
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcriptionMartina Minisini, Eros Di Giorgio, Emanuela Kerschbamer, et al.
Pageof 2